![Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the](https://c8.alamy.com/comp/2CYN7GA/incoming-teva-ceo-jeremy-levin-front-sits-with-teva-chairman-phillip-frost-c-and-outgoing-ceo-shlomo-yanai-during-a-news-conference-in-tel-aviv-january-2-2012-teva-pharmaceutical-industries-the-worlds-largest-generics-drugmaker-said-on-monday-that-yanai-would-step-down-as-president-and-chief-executive-officer-in-may-yanai-will-be-replaced-by-levin-a-former-senior-executive-at-bristol-myers-squibb-teva-said-in-a-statement-reutersnir-elias-israel-tags-business-health-drugs-society-2CYN7GA.jpg)
Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the
BioMed-MBA - Israel's first university MBA program in biomedical management - ** Full program for the Life Sciences Leadership Conference ** Register at www.volvoxleaders.com The full line-up for the conference includes: *
![Teva Chairman Phillip Frost (C) stands with outgoing CEO Shlomo Yanai (R) and incoming CEO Jeremy Levin during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's Teva Chairman Phillip Frost (C) stands with outgoing CEO Shlomo Yanai (R) and incoming CEO Jeremy Levin during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's](https://c8.alamy.com/compes/2cwn2w4/teva-chairman-phillip-frost-c-stands-with-outgoing-ceo-shlomo-yanai-r-and-incoming-ceo-jeremy-levin-during-a-news-conference-in-tel-aviv-january-2-2012-teva-pharmaceutical-industries-the-worlds-largest-generics-drugmaker-said-on-monday-that-yanai-would-step-down-as-president-and-chief-executive-officer-in-may-yanai-will-be-replaced-by-levin-a-former-senior-executive-at-bristol-myers-squibb-teva-said-in-a-statement-reuters-nir-elias-israel-tags-business-drugs-society-health-2cwn2w4.jpg)